Ryan G, Briscoe TA, Jobe L
While the initial GLP-1 MDL (MDL 3094) focuses extensively on systemic gastrointestinal injuries, such as gastroparesis, bowel obstructions, and ileus, the distinct medical, scientific, and causation arguments surrounding blindness and optic nerve damage required a targeted management framework
What Can Be Done: Proactive Steps for Optimizing Results At Revitalizing Health and Hormones, we recommend a few logical steps based on what the research is beginning to show: Before starting GLP-1 or peptide therapy, get a complete health and medication historyincluding cholesterol meds (statins), hormone levels, and metabolic labs
HbA1c improvements are typically assessed at 3 months after starting treatment and following each dose escalation